Acknowledgements |
|
vii | |
Foreword |
|
ix | |
Introduction |
|
xi | |
|
Chapter 1 The Shift towards a Connected, Assessed and Personalized Medicine Centered Upon Medical Datasphere Processing |
|
|
1 | (96) |
|
1.1 The digital gap and the medical paradigm shift |
|
|
2 | (9) |
|
1.2 The medical datasphere and its ecosystem |
|
|
11 | (43) |
|
|
14 | (12) |
|
1.2.2 The "Quantified Self and Small Data |
|
|
26 | (11) |
|
|
37 | (4) |
|
1.2.4 Clinical research based upon medical Big Data |
|
|
41 | (13) |
|
1.3 Issues surrounding the medical info-sphere |
|
|
54 | (43) |
|
1.3.1 The economic market for Big Data |
|
|
55 | (7) |
|
1.3.2 The ethical risks of using data |
|
|
62 | (12) |
|
1.3.3 The law and regulation around personal health data |
|
|
74 | (23) |
|
Chapter 2 Ethical Development of the Medical Datasphere |
|
|
97 | (70) |
|
2.1 From the study of risks to the translation of ethical issues in the medical datasphere |
|
|
100 | (26) |
|
2.1.1 The ethical systemic Neo-Platonic modeling (Ψ, G, Φ) of complex data |
|
|
101 | (4) |
|
2.1.2 The process of technical-technical guidance |
|
|
105 | (15) |
|
2.1.3 Identifying relationships between the two ontologies |
|
|
120 | (6) |
|
2.2 The selective ranking of health data |
|
|
126 | (32) |
|
2.2.1 The architecture of medical data |
|
|
126 | (18) |
|
2.2.2 Ethical Data Mining |
|
|
144 | (4) |
|
2.2.3 Ethical evaluation of medical Big Data |
|
|
148 | (10) |
|
2.3 Algorithmic ethics - the vital lead in personalized medicine |
|
|
158 | (9) |
|
Chapter 3 Management and Governance of Personal Health Data |
|
|
167 | (70) |
|
3.1 Data governance and processing algorithms |
|
|
167 | (7) |
|
3.2 The environmental digital ecosystem |
|
|
174 | (33) |
|
3.2.1 Regulatory and organizational aspects |
|
|
178 | (5) |
|
3.2.2 Relational and cultural aspects |
|
|
183 | (7) |
|
3.2.3 Structural and technological aspects |
|
|
190 | (6) |
|
3.2.4 Strategic and methodological aspects |
|
|
196 | (11) |
|
3.3 The data lifecycle: collection, processing and quality control |
|
|
207 | (14) |
|
3.4 Towards a controlled regulation of the medical datasphere |
|
|
221 | (9) |
|
3.5 Can medicine remain human? |
|
|
230 | (7) |
Conclusion |
|
237 | (6) |
Appendices |
|
243 | (2) |
Appendix 1 Advantages of Big Data Technologies According to Data Sources and Stakeholders |
|
245 | (2) |
Appendix 2 Issues Involving a Data Management Platform (DMP) |
|
247 | (2) |
Appendix 3 Evaluation Criteria on the Ethical Evaluation of Personal Health Data |
|
249 | (6) |
Appendix 4 OECD Guideline Principles Governing the Security of the Systems and Information Networks |
|
255 | (6) |
Glossary |
|
261 | (6) |
Bibliography |
|
267 | (20) |
Index |
|
287 | |